Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 79

Related Articles by Review for PubMed (Select 21852151)

1.

Immune intervention in type 1 diabetes.

Michels AW, Eisenbarth GS.

Semin Immunol. 2011 Jun;23(3):214-9. doi: 10.1016/j.smim.2011.07.003. Epub 2011 Aug 17. Review.

2.
3.

Immunotherapy of type 1 diabetes: where are we and where should we be going?

Luo X, Herold KC, Miller SD.

Immunity. 2010 Apr 23;32(4):488-99. doi: 10.1016/j.immuni.2010.04.002. Review.

4.

Gene therapy in type 1 diabetes.

Bagley J, Paez-Cortez J, Tian C, Iacomini J.

Crit Rev Immunol. 2008;28(4):301-24. Review.

PMID:
19166382
5.

Proinsulin-a pathogenic autoantigen in type 1 diabetes.

Narendran P, Mannering SI, Harrison LC.

Autoimmun Rev. 2003 Jun;2(4):204-10. Review.

PMID:
12848947
6.

Mechanistic basis of immunotherapies for type 1 diabetes mellitus.

Chen W, Xie A, Chan L.

Transl Res. 2013 Apr;161(4):217-29. doi: 10.1016/j.trsl.2012.12.017. Epub 2013 Jan 22. Review.

7.

Of mice and men: use of animal models to identify possible interventions for the prevention of autoimmune type 1 diabetes in humans.

Serreze DV, Chen YG.

Trends Immunol. 2005 Nov;26(11):603-7. Epub 2005 Sep 2. Review.

PMID:
16140038
8.

Harnessing memory adaptive regulatory T cells to control autoimmunity in type 1 diabetes.

Li CR, Baaten BJ, Bradley LM.

J Mol Cell Biol. 2012 Feb;4(1):38-47. doi: 10.1093/jmcb/mjr040. Epub 2011 Nov 24. Review.

9.

The potential role of dendritic cells in the therapy of Type 1 diabetes.

Lee CN, Lew AM, Wu L.

Immunotherapy. 2013 Jun;5(6):591-606. doi: 10.2217/imt.13.48. Review.

PMID:
23725283
10.

Antigen-based vaccination and prevention of type 1 diabetes.

Harrison LC, Wentworth JM, Zhang Y, Bandala-Sanchez E, Böhmer RM, Neale AM, Stone NL, Naselli G, Bosco JJ, Auyeung P, Rashidi M, Augstein P, Morahan G.

Curr Diab Rep. 2013 Oct;13(5):616-23. doi: 10.1007/s11892-013-0415-7. Review.

PMID:
23888323
11.

Preventing type 1 diabetes mellitus: the promise of gene therapy.

Efrat S.

Am J Pharmacogenomics. 2002;2(2):129-34. Review.

PMID:
12083947
12.

T-lymphocyte recognition of beta cells in type 1 diabetes: clinical perspectives.

Boitard C.

Diabetes Metab. 2013 Dec;39(6):459-66. doi: 10.1016/j.diabet.2013.08.001. Epub 2013 Oct 18. Review.

13.

2011 Update: antigen-specific therapy in type 1 diabetes.

Michels AW, von Herrath M.

Curr Opin Endocrinol Diabetes Obes. 2011 Aug;18(4):235-40. doi: 10.1097/MED.0b013e32834803ae. Review.

14.

Clinical potential of antigen-specific therapies in type 1 diabetes.

Coppieters KT, Sehested Hansen B, von Herrath MG.

Rev Diabet Stud. 2012 Winter;9(4):328-37. doi: 10.1900/RDS.2012.9.328. Epub 2012 Dec 28. Review.

15.

Immunotherapy of type 1 diabetes.

Li L, Yi Z, Tisch R, Wang B.

Arch Immunol Ther Exp (Warsz). 2008 Jul-Aug;56(4):227-36. doi: 10.1007/s00005-008-0025-2. Epub 2008 Jul 29. Review.

PMID:
18726144
16.

Immunotherapy for the prevention and treatment of type 1 diabetes.

Goudy KS, Tisch R.

Int Rev Immunol. 2005 Sep-Dec;24(5-6):307-26. Review.

PMID:
16318984
17.

Prevention versus intervention of type 1 diabetes.

Brooks-Worrell B, Palmer JP.

Clin Immunol. 2013 Dec;149(3):332-8. doi: 10.1016/j.clim.2013.05.018. Epub 2013 Jun 10. Review.

PMID:
23803322
18.

T cell recognition of autoantigens in human type 1 diabetes: clinical perspectives.

Mallone R, Brezar V, Boitard C.

Clin Dev Immunol. 2011;2011:513210. doi: 10.1155/2011/513210. Epub 2011 Jul 19. Review.

19.

New type of human blood stem cell: a double-edged sword for the treatment of type 1 diabetes.

Zhao Y, Lin B, Dingeldein M, Guo C, Hwang D, Holterman MJ.

Transl Res. 2010 May;155(5):211-6. doi: 10.1016/j.trsl.2010.01.003. Epub 2010 Feb 12. Review.

PMID:
20403575
20.

Innovative immune-based therapeutic approaches for the treatment of type 1 diabetes mellitus.

Eldor R, Cohen IR, Raz I.

Int Rev Immunol. 2005 Sep-Dec;24(5-6):327-39. Review.

PMID:
16318985
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk